… ytoma.
- Metabolic acidosis
- Bradycardia (less than 45-50 beats per minute)
- Hypotension
- Severe peripheral circulatory disturbances
- Concomitant intravenous use of verapamil or diltiazem
- Severe asthma and severe chronic obstructive pulmonary disease such as airway obstructions.
… the elderly, starting with a lesser dose (see Section 4.2).
Since Atenolol is excreted via the kidneys, dosage should be reduced in patients with a creatinine clearance of below 35 ml/min/1.73 m2.
Although cardioselective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with reversible obstructive airways disease, unless there are compelling clinical reasons for their use. Where such reasons exist, Atenolol may be used with caution. Occasionally, some increase in airways resistance may occur in asthmatic patients however, and this may usually be reversed by commonly used dosage of bronchodilators such as salbutamol or isoprenaline. The label and patient information leaflet for this product state the following warning: “If you have ever had asthma or wheezing, you should not take this medicine unless you have discussed these symptoms with the prescribing doctor”.
As with other beta-blockers, in patients with a phaeochromocytoma, an alpha-blocker should be given concomitantly.
Information on sodium content
This medicine contains less than 1 mmol (23 mg) o …
Identical in all 3 labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
… d be used and utmost caution must be exercised. If increased airways resistance does occur, Co-tenidone should be discontinued and bronchodilator therapy (eg salbutamol) administered if necessary.
The label and patient information leaflet for this product state the following warning: “Do not take this medicine if you have a history of wheezing or asthma.”
• systemic effects of oral beta-blockers may be potentiated when used concomitantly with ophthalmic beta-blockers.
• in patients with pheochromocytoma Co-tenidone must be administered only after …
Identical in both labels. Surrounding text shown from Wockhardt UK Ltd.
… the elderly, starting with a lesser dose (see Section 4.2).
Since Tenormin is excreted via the kidneys, dosage should be reduced in patients with a creatinine clearance of below 35 ml/min/1.73 m2.
Although cardioselective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with reversible obstructive airways disease, unless there are compelling clinical reasons for their use. Where such reasons exist, Tenormin may be used with caution. Occasionally, some increase in airways resistance may occur in asthmatic patients however, and this may usually be reversed by commonly used dosage of bronchodilators such as salbutamol or isoprenaline. The label and patient information leaflet for this product state the following warning: “If you have ever had asthma or wheezing, you should not take this medicine unless you have discussed these symptoms with the prescribing doctor”.
As with other beta-blockers, in patients with a phaeochromocytoma, an alpha-blocker should be given concomitantly.
Sodium Content
This medicine contains less than 1 mmol sodium (23 mg) per table …
Identical in both labels. Surrounding text shown from Atnahs Pharma UK Ltd.
… erly, starting with a lower dose (see section 4.2).
Since atenolol is excreted via the kidneys, the dosage should be reduced in patients with a creatinine clearance of less than 35ml/minute/1.73m2.
Although cardioselective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with reversible obstructive airways disease, unless there are compelling clinical reasons for their use. Where such reasons exist, atenolol may be used with caution. Occasionally, some increase in airways resistance may occur in asthmatic patients however, and this may usually be reversed by commonly used dosage of bronchodilators such as salbutamol or isoprenaline. The label and patient information leaflet for this product state the following warning: “If you have ever had asthma or wheezing, you should not take this medicine unless you have discussed these symptoms with the prescribing doctor”.
As with other beta-blockers, in patients with a phaeochromocytoma, an alpha-blocker should be given concomitantly.
… the elderly, starting with a lesser dose (see section 4.2).
Since atenolol is excreted via the kidneys, dosage should be reduced in patients with a creatinine clearance of below 35 ml/min/1.73 m2.
Although cardioselective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with reversible obstructive airways disease, unless there are compelling clinical reasons for their use. Where such reasons exist, atenolol may be used with caution. Occasionally, some increase in airways resistance may occur in asthmatic patients, this may usually be reversed by commonly used dosage of bronchodilators such as salbutamol or isoprenaline. The label and patient information leaflet for the product state the following warning: “If you have ever had asthma or wheezing, you should not take this medicine unless you have discussed these symptoms with the prescribing doctor”.
As with other beta-blockers, in patients with a phaeochromocytoma, an alpha-blocker should be given concomitantly.
Excipients:
This medicine contains 5.32 g sorbitol in each 20 ml (four 5 ml spoo …